Show pagesourceBacklinksCite current pageExport to PDFBack to top Share via Share via... Twitter LinkedIn Facebook Pinterest Telegram WhatsApp Yammer Reddit TeamsRecent ChangesSend via e-MailPrintPermalink × Romidepsin Attenuation of neuronal ferroptosis in intracerebral hemorrhage by inhibiting HDAC1/2: Microglial heterogenization via the Nrf2/HO1 pathwayPharmacological Landscape of FDA-Approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive MeningiomasInduction of Synthetic Lethality by Activation of Mitochondrial ClpP and Inhibition of HDAC1/2 in GlioblastomaPotent preclinical sensitivity to imipridone-based combination therapies in oncohistone H3K27M-mutant diffuse intrinsic pontine glioma is associated with induction of the integrated stress response, TRAIL death receptor DR5, reduced ClpX and apoptosisInhibition of HDAC1/2 Along with TRAP1 Causes Synthetic Lethality in Glioblastoma Model SystemsHDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma modelsTargeted Exosomes for Drug Delivery: Biomanufacturing, Surface Tagging, and ValidationHDACIs and the inhibition of invasive potential romidepsin.txt Last modified: 2024/08/29 10:34by 127.0.0.1